Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michi, Shinohara"'
Autor:
Andrew McNeil, Kesley Parks, Edward Cowen, Julia Lehman, Dominique Pichard, Michi Shinohara, Mary Flowers, Benoit Dawant, Eric Tkaczyk
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 92-92 (2024)
OBJECTIVES/GOALS: Measuring the area of skin involvement in chronic graft-versus-host disease (cGVHD) relies on costly, time-consuming manual assessment, with high disagreement among experts (>20%). Our published AI method, trained on labeled 3D phot
Externí odkaz:
https://doaj.org/article/31cf62cc98ac45d0af05406aa34826c7
Autor:
Ellen J. Kim, Aaron R. Mangold, Jennifer A. DeSimone, Henry K. Wong, Lucia Seminario-Vidal, Joan Guitart, James Appel, Larisa Geskin, Edward Lain, Neil J. Korman, Nathalie Zeitouni, Neda Nikbakht, Kenneth Dawes, Oleg Akilov, Joi Carter, Michi Shinohara, Timothy M. Kuzel, Warren Piette, Neal Bhatia, Amy Musiek, David Pariser, Youn H. Kim, Dirk Elston, Erin Boh, Madeleine Duvic, Auris Huen, Theresa Pacheco, Jeffrey P. Zwerner, Seung Tae Lee, Michael Girardi, Christiane Querfeld, Kimberly Bohjanen, Elise Olsen, Gary S. Wood, Adam Rumage, Oreola Donini, Andrea Haulenbeek, Christopher J. Schaber, Richard Straube, Christopher Pullion, Alain H. Rook, Brian Poligone
Publikováno v:
JAMA dermatology. 158(9)
ImportanceGiven that mycosis fungoides−cutaneous T-cell lymphoma (MF/CTCL) is chronic, there is a need for additional therapies with minimal short- and long-term adverse effects. Topical synthetic hypericin ointment, 0.25%, activated with visible l
Autor:
Michi Shinohara, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 1, Pp 1- (2020)
Externí odkaz:
https://doaj.org/article/c21140db11e54bb09fba5e0941acd1b2
Autor:
Caterina, Zagona-Prizio, Jenna, Yousif, Carly, Grant, Manan, Mehta, David, Rosmarin, Nanette, Silverberg, Jerry, Tan, Cecilia, Larocca, Michi, Shinohara, Arash, Mostaghimi, Brian, Kim, Susanne, Gulliver, Wayne, Gulliver, Daniel, Siegel, Lourdes, Perez-Chada, Joseph, Merola, Alice, Gottlieb, April, Armstrong
Publikováno v:
Journal of Drugs in Dermatology. 21:867-874
International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenced-based outcome measures to enhance research and treatment recommendations of
Autor:
Paul Nghiem, David M. Koelle, Thomas Blankenstein, Martin McIntosh, Gerald Willimsky, Ioannis Gavvovidis, Michi Shinohara, Lichen Jing, Kristina Lachance, Matthew P. Fitzgibbon, David Crispin, Lichun Dong, Candice D. Church, Natalie J. Miller
Tumor-infiltrating CD8+ T cells are associated with improved survival of patients with Merkel cell carcinoma (MCC), an aggressive skin cancer causally linked to Merkel cell polyomavirus (MCPyV). However, CD8+ T-cell infiltration is robust in only 4%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d294101246bde18f5f81b7a3d3fc1a61
https://doi.org/10.1158/2326-6066.c.6548345.v1
https://doi.org/10.1158/2326-6066.c.6548345.v1
Autor:
JESICA D. BARAN, DORI KHAKPOUR, ANDREA KALUS, MICHI SHINOHARA, XIAOFU DONG, DANIEL S. HIPPE, IRL B. HIRSCH
Publikováno v:
Diabetes. 71
Background: CSII is used with increased frequency; however, there are no studies evaluating human skin histology related to its use. Objectives: 1) to investigate the skin histology and metabolite changes at CSII sites and 2) associate possible chang
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB1
Autor:
Rein Willemze, Christiane Querfeld, Joya Pawade, Melissa Pulitzer, Michael T. Tetzlaff, Jinah Kim, Laura B. Pincus, Lorenzo Cerroni, E. Hong, Pierluigi Porcu, Maxime Battistella, Werner Kempf, Bethany Horton, David J. DiCaudo, Youn H. Kim, Aaron R. Mangold, Joan Guitart, Julia Scarisbrick, Alejandro A. Gru, Andras Schaffer, Gary S. Wood, Madeleine Duvic, Michi Shinohara
Publikováno v:
Am J Surg Pathol
This pathology PILOT study aims to define the role and feasibility of centralized pathology review in a cohort of 75 patients from different centers in the United States and Europe using digital slide scanning. The pathologic material from 75 patient
Autor:
Youn H. Kim, Martine Bagot, Pier Luigi Zinzani, Madeleine Duvic, Stephen Morris, Ellen Kim, Amy Musiek, Pablo L. Ortiz-Romero, Craig Elmets, Herbert A. Eradat, Nina Magnolo, Julia Scarisbrick, Stéphane Dalle, David C. Fisher, Michi Shinohara, Brian Poligone, Barbara Pro, Pietro Quaglino, Nishitha Reddy, Brigitte Dreno, Larisa J Geskin, Ahmad S Halwani, Amit Khot, Marie Beylot-Barry, Neil Korman, Frederick Lansigan, Steven M. Horwitz, Zanetta S. Lamar, Alison J. Moskowitz, Jillian Wells, Oleg E. Akilov, Dolores Caballero, Richard Cowan, Reinhard Dummer, Mary Jo Lechowicz, Francine M. Foss, Lars Iversen, Tomomitsu Miyagaki, Ryan Wilcox, Pierluigi Porcu, Maarten Vermeer, Sunil Abhyankar, Yukihiko Kato, Theresa Pacheco, Shigetoshi Sano, Basem M. William, Timothy S. Fenske, Noriko Fukuhara, Koji Habe, Toshihisa Hamada, Eiji Kiyohara, Bryone J. Kuss, Adam Lerner, Lawrence Mark, Javier Munoz, Hiroyuki Okamoto, Christiane Querfeld, Jiro Uehara, Hisashi Uhara, Kentaro Yonekura, Auris Huen, Kensei Tobinai, Yoshiki Tokura, Erin Boh, Jan Nicolay, Hidefumi Wada, Mollie Leoni, Takahiro Ito, Fiona Herr, Lubomir Sokol
Publikováno v:
Blood. 134:5300-5300
Introduction: MAVORIC was an open-label, multicenter, randomized phase 3 study evaluating the safety and efficacy of mogamulizumab (moga) compared to vorinostat (vori) in patients with mycosis fungoides (MF) or Sézary syndrome (SS) who had failed at